Quantitative aspects of drug and toxicant-induced astrogliosis

[1]  S. Peroutka.  Serotonin Receptor Subtypes , 1995 .

[2]  J. Trojanowski,et al.  Immunohistochemical detection of the effects of toxic injury on the central nervous system , 1995, Neurochemistry International.

[3]  C. Finch,et al.  Gonadal steroids regulate the expression of glial fibrillary acidic protein in the adult male rat hippocampus , 1993, Neuroscience.

[4]  K. Crofton,et al.  Administration of 3,3'-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem. , 1993, The Journal of pharmacology and experimental therapeutics.

[5]  M. Frotscher,et al.  Light‐ and Electron‐Microscopic Studies of Identified Septohippocampal Neurons Surviving Axotomy 1 , 1993 .

[6]  J. O'Callaghan.  Quantitative Features of Reactive Gliosis following Toxicant‐induced Damage of the CNS a , 1993, Annals of the New York Academy of Sciences.

[7]  C. Goodlett,et al.  Transient cortical astrogliosis induced by alcohol exposure during the neonatal brain growth spurt in rats. , 1993, Brain research. Developmental brain research.

[8]  E. Rubel,et al.  Rapid and reversible astrocytic reaction to afferent activity blockade in chick cochlear nucleus , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  J. O'Callaghan.  The Use of Glial Fibrillary Acidic Protein in First-Tier Assessments of Neurotoxicity , 1991 .

[10]  B. McEwen,et al.  Glucocorticoids Regulate the Synthesis of Glial Fibrillary Acidic Protein in Intact and Adrenalectomized Rats but Do Not Affect Its Expression Following Brain Injury , 1991, Journal of neurochemistry.

[11]  O. Steward,et al.  Neuronal activity up-regulates astroglial gene expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  O'Callaghan Jp,et al.  Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. , 1991, Biomedical and environmental sciences : BES.

[13]  M. Kalia.  Reversible, short-lasting, and dose-dependent effect of (+)-fenfluramine on neocortical serotonergic axons , 1991, Brain Research.

[14]  J. O'Callaghan.  Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. , 1991, Neurotoxicology and teratology.

[15]  R. Switzer.  Strategies for assessing neurotoxicity , 1991, Neuroscience & Biobehavioral Reviews.

[16]  N. Laping,et al.  Castration enhances expression of glial fibrillary acidic protein and sulfated glycoprotein-2 in the intact and lesion-altered hippocampus of the adult male rat. , 1990, Molecular endocrinology.

[17]  M. Wilson,et al.  Neurotoxicity of MDMA and Related Compounds: Anatomic Studies a , 1990, Annals of the New York Academy of Sciences.

[18]  J. O'Callaghan,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP , 1990, Neuroscience Letters.

[19]  J. O'Callaghan,et al.  Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1990, Brain Research.

[20]  J. Cronly-Dillon,et al.  Preferential histochemical staining of protoplasmic and fibrous astrocytes in rat CNS with GFAP antibodies using different fixatives , 1990, Brain Research.

[21]  P. Duffy.  The Biochemical Pathology of Astrocytes , 1989 .

[22]  B. McEwen,et al.  Glucocorticoids regulate the concentration of glial fibrillary acidic protein throughout the brain , 1989, Brain Research.

[23]  J. Cadet.  The iminodipropionitrile (IDPN)-induced dyskinetic syndrome: Behavioral and biochemical pharmacology , 1989, Neuroscience & Biobehavioral Reviews.

[24]  M. Gilbert.  The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures , 1988, Brain Research.

[25]  J. O'Callaghan.  Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. , 1988, Neurotoxicology and teratology.

[26]  C. Balaban,et al.  Trimethyltin-induced neuronal damage in the rat brain: Comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins , 1988, Neuroscience.

[27]  L S Seiden,et al.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.

[28]  J. O'Callaghan,et al.  Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  J. O'Callaghan,et al.  Diethyldithiocarbamate increases distribution of cadmium to brain but prevents cadmium-induced neurotoxicity , 1986, Brain Research.

[30]  J. O'Callaghan,et al.  Cerebellar hypoplasia in the Gunn rat is associated with quantitative changes in neurotypic and gliotypic proteins. , 1985, The Journal of pharmacology and experimental therapeutics.

[31]  P. Greengard,et al.  A quantitative dot-immunobinding assay for proteins using nitrocellulose membrane filters. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Duffy.  Astrocytes: Normal, Reactive, and Neoplastic , 1983 .

[33]  J. Javitch,et al.  Recognition sites for norepinephrine uptake: regulation by neurotransmitter. , 1983, Science.

[34]  J. D. Olmos,et al.  A modified cupric-silver technique for the impregnation of degenrating neurons and their processes , 1981, Brain Research.

[35]  H. A. Hartmann,et al.  THE DISTRIBUTION OF NEUROAXONAL LESIONS IN MICE INJECTED WITH IMINODIPROPIONITRILE WITH SPECIAL REFERENCE TO THE VESTIBCLAR SYSTEM , 1965, Journal of neuropathology and experimental neurology.

[36]  Miller Db,et al.  Quantification of reactive gliosis as an approach to neurotoxicity assessment. , 1993 .

[37]  J. O'Callaghan,et al.  Mapping toxicant-induced nervous system damage with a cupric silver stain: a quantitative analysis of neural degeneration induced by 3,4-methylenedioxymethamphetamine. , 1993, NIDA research monograph.

[38]  L. Heimer,et al.  Silver staining as a tool for neurotoxic assessment. , 1993, NIDA research monograph.

[39]  R. Isaacson,et al.  Malnutrition and hazard assessment , 1992 .

[40]  J. O'Callaghan,et al.  Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. , 1992, Neurotoxicology.

[41]  S. Peroutka.  Serotonin receptor subtypes : basic and clinical aspects , 1991 .

[42]  J. Sutcliffe,et al.  mRNA in the mammalian central nervous system. , 1988, Annual review of neuroscience.

[43]  Sergey Fedoroff,et al.  Cell biology and pathology of astrocytes , 1986 .